title: Crystalline cardiomyopathy due to secondary oxalosis after short-bowel syndrome and end-stage renal failure.
authors.affiliation: Department of Cardiovascular Medicine, Nippon Medical School, 1-1-5 Sendagi, Bunkyo-ku, Tokyo, 113-8603, Japan. tnsaitonms@gmail.com.
authors.forename: Tsunenori
authors.initials: T
authors.lastname: Saito
authors.affiliation: Department of Nephrology, Nippon Medical School, Tokyo, Japan.
authors.forename: Mariko
authors.initials: M
authors.lastname: Ikeda
authors.affiliation: Department of Cardiovascular Medicine, Nippon Medical School, 1-1-5 Sendagi, Bunkyo-ku, Tokyo, 113-8603, Japan.
authors.forename: Kuniya
authors.initials: K
authors.lastname: Asai
authors.affiliation: Department of Cardiovascular Medicine, Nippon Medical School, 1-1-5 Sendagi, Bunkyo-ku, Tokyo, 113-8603, Japan.
authors.forename: Wataru
authors.initials: W
authors.lastname: Shimizu
mesh_terms: D000328:Adult; D001706:Biopsy; D002129:Calcium Oxalate / Q000032:analysis*; D009202:Cardiomyopathies / Q000175:diagnosis / Q000209:etiology* / Q000503:physiopathology; D003460:Crystallization; D005260:Female; D005355:Fibrosis; D006801:Humans; D006959:Hyperoxaluria / Q000175:diagnosis / Q000209:etiology*; D007676:Kidney Failure, Chronic / Q000150:complications* / Q000175:diagnosis / Q000628:therapy; D008854:Microscopy, Electron; D009206:Myocardium / Q000737:chemistry* / Q000648:ultrastructure; D010289:Parenteral Nutrition, Total; D006435:Renal Dialysis / Q000009:adverse effects; D012778:Short Bowel Syndrome / Q000150:complications* / Q000175:diagnosis / Q000628:therapy; D016896:Treatment Outcome; D016277:Ventricular Function, Left
chemical_list: D002129:Calcium Oxalate